vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.

Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $19.2M, roughly 1.7× Apyx Medical Corp). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -6.8%, a 6.4% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 2.7%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

APYX vs SAMG — Head-to-Head

Bigger by revenue
SAMG
SAMG
1.7× larger
SAMG
$32.0M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+34.8% gap
APYX
34.7%
-0.0%
SAMG
Higher net margin
SAMG
SAMG
6.4% more per $
SAMG
-0.4%
-6.8%
APYX
More free cash flow
SAMG
SAMG
$17.8M more FCF
SAMG
$15.0M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
2.7%
SAMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
SAMG
SAMG
Revenue
$19.2M
$32.0M
Net Profit
$-1.3M
$-120.0K
Gross Margin
62.6%
Operating Margin
0.1%
-2.8%
Net Margin
-6.8%
-0.4%
Revenue YoY
34.7%
-0.0%
Net Profit YoY
71.9%
-107.4%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
SAMG
SAMG
Q4 25
$19.2M
$32.0M
Q3 25
$12.9M
$31.3M
Q2 25
$11.4M
$30.7M
Q1 25
$9.4M
$31.4M
Q4 24
$14.2M
$32.0M
Q3 24
$11.5M
$30.4M
Q2 24
$12.1M
$31.0M
Q1 24
$10.2M
$30.3M
Net Profit
APYX
APYX
SAMG
SAMG
Q4 25
$-1.3M
$-120.0K
Q3 25
$-2.0M
$618.0K
Q2 25
$-3.8M
$1.9M
Q1 25
$-4.2M
$2.5M
Q4 24
$-4.6M
$1.6M
Q3 24
$-4.7M
$2.3M
Q2 24
$-6.6M
$2.7M
Q1 24
$-7.6M
$3.0M
Gross Margin
APYX
APYX
SAMG
SAMG
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
SAMG
SAMG
Q4 25
0.1%
-2.8%
Q3 25
-6.5%
4.3%
Q2 25
-22.6%
13.2%
Q1 25
-32.4%
15.4%
Q4 24
-21.4%
6.1%
Q3 24
-31.6%
14.6%
Q2 24
-45.7%
17.1%
Q1 24
-64.6%
19.5%
Net Margin
APYX
APYX
SAMG
SAMG
Q4 25
-6.8%
-0.4%
Q3 25
-15.4%
2.0%
Q2 25
-33.2%
6.3%
Q1 25
-44.0%
7.9%
Q4 24
-32.5%
5.1%
Q3 24
-40.9%
7.4%
Q2 24
-54.0%
8.6%
Q1 24
-74.0%
9.9%
EPS (diluted)
APYX
APYX
SAMG
SAMG
Q4 25
$0.02
Q3 25
$0.07
Q2 25
$0.21
Q1 25
$0.26
Q4 24
$0.16
Q3 24
$0.24
Q2 24
$-0.19
$0.28
Q1 24
$-0.22
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
SAMG
SAMG
Cash + ST InvestmentsLiquidity on hand
$31.7M
$44.1M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$50.3M
Total Assets
$66.8M
$166.6M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
SAMG
SAMG
Q4 25
$31.7M
$44.1M
Q3 25
$25.1M
$36.1M
Q2 25
$29.3M
$30.0M
Q1 25
$31.0M
$36.3M
Q4 24
$31.7M
$68.6M
Q3 24
$28.0M
$58.1M
Q2 24
$32.7M
$49.9M
Q1 24
$37.3M
$39.7M
Total Debt
APYX
APYX
SAMG
SAMG
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
SAMG
SAMG
Q4 25
$14.5M
$50.3M
Q3 25
$5.8M
$58.9M
Q2 25
$7.3M
$64.6M
Q1 25
$10.5M
$80.0M
Q4 24
$14.2M
$80.7M
Q3 24
$11.0M
$84.6M
Q2 24
$14.7M
$85.3M
Q1 24
$20.3M
$83.9M
Total Assets
APYX
APYX
SAMG
SAMG
Q4 25
$66.8M
$166.6M
Q3 25
$57.4M
$157.6M
Q2 25
$58.2M
$152.7M
Q1 25
$60.2M
$159.9M
Q4 24
$64.8M
$194.4M
Q3 24
$60.7M
$184.2M
Q2 24
$65.4M
$177.6M
Q1 24
$70.7M
$170.2M
Debt / Equity
APYX
APYX
SAMG
SAMG
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
SAMG
SAMG
Operating Cash FlowLast quarter
$-2.5M
$18.6M
Free Cash FlowOCF − Capex
$-2.8M
$15.0M
FCF MarginFCF / Revenue
-14.6%
46.9%
Capex IntensityCapex / Revenue
1.4%
11.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
SAMG
SAMG
Q4 25
$-2.5M
$18.6M
Q3 25
$-3.5M
$14.6M
Q2 25
$-1.2M
$13.8M
Q1 25
$-702.0K
$-24.7M
Q4 24
$-2.9M
$21.6M
Q3 24
$-4.4M
$13.3M
Q2 24
$-4.3M
$16.0M
Q1 24
$-6.3M
$-24.1M
Free Cash Flow
APYX
APYX
SAMG
SAMG
Q4 25
$-2.8M
$15.0M
Q3 25
$-4.1M
$13.8M
Q2 25
$-1.5M
$13.4M
Q1 25
$-757.0K
$-25.1M
Q4 24
$-3.2M
$19.9M
Q3 24
$-4.6M
$12.9M
Q2 24
$-4.6M
$15.6M
Q1 24
$-6.4M
$-24.7M
FCF Margin
APYX
APYX
SAMG
SAMG
Q4 25
-14.6%
46.9%
Q3 25
-31.5%
44.1%
Q2 25
-13.2%
43.6%
Q1 25
-8.0%
-80.0%
Q4 24
-22.4%
62.2%
Q3 24
-40.0%
42.4%
Q2 24
-38.0%
50.4%
Q1 24
-62.2%
-81.6%
Capex Intensity
APYX
APYX
SAMG
SAMG
Q4 25
1.4%
11.4%
Q3 25
4.0%
2.6%
Q2 25
2.3%
1.5%
Q1 25
0.6%
1.3%
Q4 24
1.7%
5.3%
Q3 24
1.3%
1.2%
Q2 24
2.4%
1.1%
Q1 24
0.3%
2.0%
Cash Conversion
APYX
APYX
SAMG
SAMG
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

Related Comparisons